Docusol
DocuSol® Kids mini-enemas
Many over-the-counter treatments for children’s constipation contain bisacodyl, a known irritant. DocuSol® Kids, a first-of-its kind formula, does not. The non-irritating DocuSol® formulation functions as a stool-softening, hyperosmotic laxative by drawing water into the bowel from surrounding body tissues, replicating a normal bowel stimulus. This unique formulation provides children ages 2–12 fast, predictable relief of constipation.
DocuSol® Kids was designed for easy use at home. The DocuSol® Kids tube is designed to offer a minimally invasive, soft, and flexible tip, avoiding any scratching or irritation to the skin. Just a 5 milliliter tube delivering 100mg of docusate sodium, the medication provides fast relief in just a few, easy steps! See package for instructions.
DocuSol® mini-enemas
Constipation is the most common gastrointestinal complaint in the United States. An estimated 42 million individuals have bowel issues or constipation. The docusate sodium DocuSol® mini-enema has been used by patients and healthcare facilities for over 15 years.
DocuSol® Plus mini-enemas
Docusate sodium in a proprietary blend of polyethylene glycol & glycerine with benzocaine to assist in the anesthetization of the rectum and lower bowel.
DocuSol® Kids Product Benefits:
- Fast, predictable results
- Non-irritating formula
- Easy rectal usage, soft flexible tip
- Affordably priced for constipation relief
- Ease of use for both clinicians and parents
- Rectal therapy for those children unwilling to swallow medications
DocuSol® Product Benefits:
- Fast, predictable results
- Flexible tip for ease of use at home
- Non-irritating formula
- Easy rectal usage for patients with reflux issues or nausea
- Affordably priced, conveniently packaged in 5 count box
- DocuSol® is covered in approximately 78% of the United States by Medicaid
- Many private insurance plans cover the cost of DocuSol®. Individuals should contact their insurance provider to verify that DocuSol® is covered on their plan
Source: 1. Federal Register / Vol. 50, No. 10 / Tuesday, January 15 1985 / Proposed Rules; pgs 2124-2158. 2. Rehabilitation Nursing (Dunn KL & Galka ML (1994) Comparison of the Effect of Therevac SB and Bisacodyl Suppositories in SCI Patients Bowel Programs, Rehabil Nurs. 19 (6):334-8. 3. Alliance Labs In-house research. Customer Survey April 27, 2011. 4. Mode of Action. Alliance Labs in-house research customer survey Feb. 21, 2014.
GPOs
Vizient | MHA | Intalere | MMCAP| HealthTrust | GeriMed | PDM | Premier | VA-DOD| Kaiser | Pharmacy Select
Distributors
Smith Drug Co | Morris & Dickson | Value Drug Co | Byram Healthcare